Body Mass Index and Clinical Outcomes from Endoscopic Submucosal Dissection of Gastric Neoplasia
Sign Up to like & getrecommendations! Published in 2017 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-017-4560-8
Abstract: AbstractBackground and AimAssociation between obesity and endoscopic resection outcomes has not been investigated. We sought to determine the clinical impact of obesity in patients who underwent endoscopic submucosal dissection (ESD) for gastric neoplasia.MethodsA total of… read more here.
Keywords: endoscopic submucosal; body mass; clinical outcomes; gastric neoplasia ... See more keywords
Epigenetic regulation of Wnt/β‐catenin signal‐associated genes in gastric neoplasia of the fundic gland (chief cell‐predominant) type
Sign Up to like & getrecommendations! Published in 2017 at "Pathology International"
DOI: 10.1111/pin.12509
Abstract: Gastric neoplasia of the fundic gland (chief cell‐predominant) type (GNCCP) is a rare variant of gastric tumor. This tumor is associated with activation of the Wnt/β‐catenin signaling pathway; however, the mechanisms underlying this activation remain… read more here.
Keywords: gastric neoplasia; fundic gland; neoplasia fundic; gnccps ... See more keywords
Abstract 4095: Active Kras induced metaplasia progression toward gastric neoplasia is suppressed by MEK inhibition during gastric carcinogenesis
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-4095
Abstract: Intestinal type gastric cancer develops within metaplastic mucosal fields and development of gastric neoplasia represents the most prominent example of gastric cancer developing within the morphologic changes of metaplasia. Recent investigations have noted activation of… read more here.
Keywords: gastric neoplasia; mek inhibition; active kras; cancer ... See more keywords